hysician goes through the review process for an imaging exam, AIM provides price and capability information that can be used by the physician to select an imaging facility. After the review process is completed, OptiNet
compares the price and capability scoring for the imaging facility selected during the review process with other facilities located in the same geographic area. If the program finds another facility that offers comparable or better capabilities at a lower price, an AIM representative proactively calls the consumer to provide this information to the consumer. While wholly voluntary, if the consumer decides to switch to an alternative imaging facility for the exam, AIM provides assistance in scheduling the service.
"Our program was developed in partnership with or affiliated health plans and empowers consumers by giving them information that they can use to make a decision that's best for them," said Cady. "As employers and health plan members take a greater role in financing their health care, OptiNet represents the type of service that can help promote the affordability of health care services in the United States. Providers should be competing on quality, capabilities and price – and consumers should have easy access to that information."
The OptiNet member transparency tool for CT scans and MRIs is being piloted with WellPoint's affiliated health plan in Indiana within a nine-county Indianapolis market where AIM and the health plan identified a broad cost difference among advanced diagnostic imaging procedures. The cost variance for CT scans was more than $1,000 in many instances, while the variance for more expensive MRI procedures was almost $2,000.
"This program represents and underscores our commitment to helping improve quality and cost effectiveness in the delivery of health care services to our affiliated health plan members," says Anthon
Page: 1 2 3 4 Related medicine technology :1
|SOURCE American Imaging Management, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting2
. Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting3
. Giant Eagle® Receives American Diabetes Association Chairmans Citation Award4
. American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4% 30 mL Single Dose Vials and 100 mL Pharmacy Bulk Packs5
. American Regent Initiates Voluntary Nationwide Recall of Bacteriostatic Sodium Chloride Injection, USP, 0.9% 30 mL Multiple Dose Vials6
. American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland7
. American Oriental Bioengineering to Announce Fourth Quarter and Full Year 2010 Financial Results on March 14, 20118
. Neuro Kinetics Presenting New Balance & Dizziness Research at American Balance Society Conference9
. CVS Caremark and Universal American Announce Termination of Hart-Scott-Rodino Waiting Period10
. Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened11
. MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology